Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Brain Neoplasms 6Glioblastoma 5Childhood Brain Neoplasm 2Neurodegenerative Diseases 1Ischemic Stroke 1Hypoxia 1Hemorrhagic Stroke 1Glioma 1Cranial Nerve Diseases 1Central Nervous System Vascular Malformations 1Central Nervous System Neoplasms 1Central Nervous System Infections 1Brain Injuries 1Adult Brain Glioblastoma 1

Interventions

Ferrosoferric Oxide 2Tissue Array Analysis 1Surgical Procedures, Operative 1Gadolinium 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Diagnosis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Childhood Brain Neoplasm × Ferrosoferric Oxide × CNS × Clear all
NCT03179449 2023-04-14

In Vivo Characterization of Macrophages in Pediatric Patients With Malignant Brain Tumors Using Ferumoxytol-enhanced MRI

Stanford University

Phase EARLY_PHASE1 Withdrawn
CNS

Childhood Brain Neoplasm

NCT00978562 2022-08-03

DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors

OHSU Knight Cancer Institute

Phase EARLY_PHASE1 Completed
14 enrolled 8 charts
CNS

Childhood Brain Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡